Direct oral anticoagulants (DOACs)

被引:9
|
作者
Vazquez, Sara [1 ]
Rondina, Matthew T. [2 ,3 ,4 ]
机构
[1] Univ Utah, Hlth Sci Ctr, Univ Healthcare Thrombosis Serv, Salt Lake City, UT USA
[2] Univ Utah, Dept Internal Med, Div Gen Internal Med, Salt Lake City, UT 84112 USA
[3] Univ Utah, Sch Med, Program Mol Med, Salt Lake City, UT USA
[4] George E Wahlen Salt Lake City VAMC, Dept Internal Med, Salt Lake City, UT USA
关键词
anticoagulants; apixaban; dabigatran; edoxaban; rivaroxaban; thrombosis; DVT; pulmonary embolism; PATIENT;
D O I
10.1177/1358863X15600256
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
DOACs are a new group of blood-thinner medications that may have some advantages over warfarin. A health care provider will look at several different factors to help patients decide if a DOAC is a good choice. Patients taking DOACs should discuss medication changes, a plan for taking the DOAC before and after a surgery, and any bleeding side effects with their health care provider.
引用
收藏
页码:575 / 577
页数:3
相关论文
共 50 条
  • [31] Measurement and reversal of the direct oral anticoagulants
    Samuelson, Bethany T.
    Cuker, Adam
    BLOOD REVIEWS, 2017, 31 (01) : 77 - 84
  • [32] A New Generation of Oral Direct Anticoagulants
    Soff, Gerald A.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2012, 32 (03) : 569 - 574
  • [33] Laboratory Assessment of Direct Oral Anticoagulants
    Douxfils, Jonathan
    Gosselin, Robert C.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2017, 43 (03): : 277 - 290
  • [34] Treatment Failures of Direct Oral Anticoagulants
    Kajy, Marvin
    Mathew, Anil
    Ramappa, Preeti
    AMERICAN JOURNAL OF THERAPEUTICS, 2021, 28 (01) : E87 - E95
  • [35] Assessment of exposure to direct oral anticoagulants in elderly hospitalised patients
    Kampouraki, Emmanouela
    Avery, Peter
    Biss, Tina
    Wynne, Hilary
    Kamali, Farhad
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 195 (05) : 790 - 801
  • [36] Direct oral anticoagulants and travel-related venous thromboembolism
    Chamnanchanunt, Supat
    Rojnuckarin, Ponlapat
    OPEN MEDICINE, 2018, 13 (01): : 575 - 582
  • [37] Association of Direct Oral Anticoagulants (DOACs) and Warfarin With Haemorrhagic Risk by Applying Correspondence Analysis to Data From the Italian Pharmacovigilance Database - A Case Study
    Gaio, Mario
    Ferrajolo, Carmen
    Zinzi, Alessia
    Riccardi, Consiglia
    Di Filippo, Pasquale
    Carangelo, Ludovica
    Pieretti, Gorizio
    Rossi, Francesco
    Nicoletti, Giovanni Francesco
    Capuano, Annalisa
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [38] Dermatosurgery in the age of novel oral anticoagulants/direct oral anticoagulants
    Loeser, C.
    Nast, A.
    Zeymer, U.
    HAUTARZT, 2019, 70 (11): : 850 - 853
  • [39] Use of direct oral anticoagulants in daily practice
    Almarshad, Feras
    Alaklabi, Ali
    Bakhsh, Ebtisam
    Pathan, Aslam
    Almegren, Mosaad
    AMERICAN JOURNAL OF BLOOD RESEARCH, 2018, 8 (04): : 57 - 72
  • [40] Direct oral anticoagulants in the treatment of pulmonary embolism
    Eldredge, Joanna B.
    Spyropoulos, Alex C.
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (01) : 131 - 140